The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.20 to $53.26, inclusive. The reporting person undertakes to provide Flowserve Corporation, any security holder of Flowserve Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.


Common stock

Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated August 8, 2022.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

The restricted stock units were granted on August 8, 2022. Beginning on August 8, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.

/s/ William Cook, as Attorney in Fact for Brian Goff


The ending balance differs from amounts previously reported due to shares acquired under a dividend reinvestment plan.

Voluntary Cash for DRIP.


Restricted Stock Units (MSPP Purchased Award)

Common Stock

Restricted Stock Units (MSPP Matching Award)

Common Stock

Restricted stock units (MSPP Purchased Award) are fully vested upon grant; however, settlement occurs upon the earlier of termination of employment or three years from grant date.

Represents settlement date for restricted stock units (MSPP Purchased Award). Restricted stock units do not expire; they either vest or are canceled prior to vesting date.

Represents vesting date for these restricted stock units.

Reporting person was awarded the restricted stock units (MSPP Matching Award) in connection with voluntary participation in a management stock purchase program (MSPP).


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $644.45 to $645.11, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Includes 16 shares previously held in a family member's retirement account.

On May 15, 2025, 5,340 shares of Eli Lilly and Company common stock were transferred to the reporting person as an annuity payment in accordance with the terms of the Grantor Retained Annuity Trust, of which the reporting person is the trustee.

The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

/s/ Jonathan Groff for David A. Ricks, pursuant to authorization on file


/s/ James A. Hart, attorney-in-fact for Joaquin Delgado


Shares withheld by Registrant to satisfy tax withholding obligations on vesting of restricted stock units.

/s/ Patricia A . Comai, POA for Jason W. Vasquez


These shares were acquired through exempt dividend reinvestment transactions and are being voluntarily reported.


Common Stock

Common Stock

Restricted stock units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs.

On August 1, 2022, the reporting person was granted RSUs. On August 1, 2025, the reporting person reported that previously awarded RSUs, including dividend equivalents, vested and converted to Carrier common stock. Those previously awarded RSUs were entitled to additional dividend equivalents that were not payable until August 8, 2025.


Common Stock

Common Stock


by a trust where his wife and children serve as beneficiaries


/s/ Robert D. Fatovic, by power of attorney


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $634.21 to $634.42, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

On March 10, 2025, the Reporting Person's spouse transferred 2,510 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's spouse is the trustee and the Reporting Person's spouse and children are beneficiaries.

/s/ Jonathan Groff for Daniel Skovronsky, pursuant to authorization on file


Common Stock

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $262.150 - $263-185, inclusive.  The reporting person undertakes to provide to Broadridge Financial Solutions, Inc., any shareholder of Broadridge Financial Solutions, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.


/s/ Patricia A. Comai POA for Kurt Loring


The price reported in Column 4 represents the weighted average price per share of open market purchase transactions. The actual purchase prices ranged from a low of $145.84 per share to a high of $146.00 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.


Common

Common

The price reported in Column 4 is a weighted average price.  The shares were sold in multiple transactions at prices ranging from $388.085 - $388.18.  The reporting person undertakes to provide to Cummins Inc., any security holder of Cummins Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range indicated.

/s/ Nicole Y. Lamb-Hale, Attorney-in-Fact


The Reporting Person gifted shares to four trusts, the beneficiaries of which are the Reporting Person's grandchildren.

The Reporting Person is the trustee for four trusts, the beneficiaries of which are the Reporting Person's grandchildren. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

The Reporting Person's spouse is the trustee for a trust, the beneficiary of which is the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

The Reporting Person is a co-trustee for a trust, the beneficiary of which is the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.


/s/ David G. Turner by Charles Mosher, Power of Attorney


The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.835 to $20.105 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares are held in The Edward and Maureen Kennedy Living Trust.

/s/ Katayoun ("Katy") Motiey, Power of Attorney for Edward H. Kennedy


/s/ Lynn McKee by Charles K. Mosher Attorney-in-Fact


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $54.18 to $54.25, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form-4.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $58.06 to $58.5, inclusive. The reporting person undertakes to provide Claritev Corporation, any security holder of Claritev Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.


/s/ Jonathan Groff for Gabrielle Sulzberger, pursuant to authorization on file


Reflects performance share units that will settle on August 15, 2025.


/s/ Christopher T. Gheysens by Charles K. Mosher, Attorney-in-Fact


/s/ Nancy Foster by Charles Mosher, Power of Attorney


Includes shares acquired through employee stock plans, shares purchased with reinvested dividends and restricted stock units as of August 08, 2025.

Reflects the gift of common stock to a charitable donor advised fund.

Includes shares acquired through employee stock plans, shares purchased with reinvested dividends and restricted stock units as of August 11, 2025.

/s/ Nicole V. Gersch, on behalf of J. McGregor Carr through Power of Attorney


These shares are held in a trust for the benefit of the reporting person's children. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

/s/ Eleuthere I. du Pont by Charles Mosher, Power of Attorney


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $641.49 to $642.27 (row 1), and $642.50 to $642.97 (row 2), respectively. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

/s/ Jonathan Groff for J. Erik Fyrwald, pursuant to authorization on file


/s/ Michael J. Donahue,  by Charles K. Mosher, Attorney-in-Fact


Represents shares withheld by the issuer to satisfy tax withholding requirements on vesting of restricted stock units and does not represent a sale.

/s/ Paul Bokota, Attorney-in-fact for Michael Monahan


/s/ Eric J. Sorenson, Jr., POA for Michael A. Syrek


Shares withheld by Registrant to satisfy tax withholding obligations on vesting of restricted stock units.

/s/ Patricia A. Comai POA for Warren E. Hoffner, III


/s/ Jennifer W. Davis by Charles Mosher, Power of Attorney


Includes shares acquired through employee stock plans, shares purchased with reinvested dividends and restricted stock units as of August 8, 2025.

/s/ Nicole V. Gersch, on behalf of Allysun C. Fleming through Power of Attorney


The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 12, 2025.

/s/ Jonathan Groff for Ilya Yuffa, pursuant to authorization on file


/s/ Karen Dougherty by Charles K. Mosher, Attorney-in-Fact


Common Stock, par value $0.0001 per share

Includes 580 shares acquired through Redwire Corporation's employee stock purchase plan.

/s/ James H. Romaker, by Power of Attorney


/s/ Francis B. Brake by Charles Mosher, Power of Attorney


Jane R. Grimm, Attorney-in-fact, for Bryan A. Hanley, Senior VP and Treasurer


The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $70.9600 to $71.9000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Held by the F. Thomson Leighton and Bonnie B. Leighton Revocable Trust dtd 11/3/99 of which Mr. Leighton serves as a trustee. Mr. Leighton disclaims beneficial ownership of shares held by such trust except to the extent of his pecuniary interest therein.

Includes 10,481 shares received pursuant to a distribution from the David T. Leighton trust, of which the Reporting Person served as trustee. Such distribution was made in accordance with the exemptions afforded under 16a-9 and 16a-13.

The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $71.9800 to $72.9350, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Held by the TBL Foundation of which Mr. Leighton serves as a trustee.

/s/ Thomas M. Lair, by power of attorney


/s/ Anat Bird by Charles Mosher, Power of Attorney


Common Stock

Common Stock

The shares were sold in multiple transactions at prices ranging from $79.8000 to $80.7800 per share on August 8, 2025.  The $80.4868 sale price reported above is the weighted average sale price.  The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The shares were sold in multiple transactions at prices ranging from $80.8100 to $80.8700 per share on August 8, 2025.  The $80.8359 sale price reported above is the weighted average sale price.  The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The shares are held by a trust over which the reporting person has investment control but is not the trustee.

The option vested in three equal annual installments  on February 13, 2019, 2020, and 2021.

Jessica Vu, Attorney-in-Fact for Thomas L. Ryan


/s/Patricia A. Comai POA for Neil A. Schrimsher


Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the reporting person.


Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person.


Represents shares of common stock held by Madryn Health Partners II, LP ("Health Partners"), for which Madryn Asset Management, LP ("Madryn") serves as the investment advisor.

Madryn Health Advisors II, LP ("Health Advisors"), as general partner of Health Partners and Madryn Health Partners II (Cayman Master), LP ("Cayman Master"); Madryn Health Advisors GP II, LLC, as general partner of Health Advisors; Madryn Select Advisors, LP ("Select Advisors") as general partner of Madryn Select Opportunities, LP ("Select Opportunities"); and Madryn Select Advisors GP, LLC, as general partner of Select Advisors, may be deemed to be beneficial owners of the shares held directly by Health Partners, Cayman Master and Select Advisors, respectively.

Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest.

Represents shares of common stock held by Cayman Master, for which Madryn serves as the investment advisor.

Represents shares of common stock held by Select Opportunities, for which Madryn serves as the investment advisor.


The shares of Common Stock were sold pursuant to a 10b5-1 plan adopted by the Reporting Person on February 20, 2025.


Reflects performance share units that will settle on August 15, 2025.


Jane R. Grimm, Attorney-in-fact, for Bart W. Reichert, Vice President, Internal Audit


Common Stock

This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on May 6, 2024.

Shares held of record by Barry R. Port and Michelle Port, spouse of the Reporting Person, Trustees.

These shares were granted August 31, 2016 and vested over 5 equal annual installments.

/s/ Chad A. Keetch, as power of attorney


By Virginia Bradley Irby Equalization Trust

By Elizabeth Neal Irby Equalization Trust

Purchased through Issuer's Director Stock Purchase Plan.


Fixed/Floating Rate Non-Cum Perpetual Preferred Stock Ser D

Fixed-Rate Reset Non Cum Perpetual Preferred Stock Ser E


On April 25, 2025, the reporting person contributed 72,000 shares of KeyCorp common stock to a grantor retained annuity trust for the benefit of himself and his children. Upon termination of a separate grantor retained annuity trust on August 9, 2025, 39,406 shares of KeyCorp common stock were transferred to the reporting person's children. The remaining 50,000 shares in such trust were returned to the reporting person and continue to be reported in this Form 4 as directly owned.

Reported as of July 24, 2025.

Adam J. Larkins POA for Andrew J. Paine III


The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $72.05 to $72.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote

/s/ Kristin Eberhart, by power of attorney


The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.86 to $12.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the
Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Includes 290 shares underlying Restricted Stock Units allocated but not yet vested or delivered.

/s/ Seth G. Schuknecht, attorney-in fact


Common Stock

Common Stock

Common Stock

Common Stock

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $65.5315 to $65.5350, inclusive.  The reporting person undertakes to provide to Corning Incorporated, any security holder of Corning Incorporated, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth previously in this footnote.

Each restricted stock unit represents a contingent right to receive one share of Corning Incorporated common stock.

The restricted stock units (RSUs) vest 100% on April 15, 2027. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 14, 2028. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 15, 2026. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) granted on February 8, 2023 vest 1/3 after 1 year from the grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.


Comomn Stock

Comomn Stock

The shares were sold in multiple transactions at prices ranging from $79.5400 to $80.5350 per share on August 8, 2025.  The $80.2730 sale price reported above is the weighted average sale price.  The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The shares were sold in multiple transactions at prices ranging from $80.5400 to $80.7300 per share on August 8, 2025.  The $80.5982 sale price reported above is the weighted average sale price.  The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

The option vested in three equal installments on February 13, 2019, 2020, and 2021.

Jessica Vu, Attorney-in-Fact for John H. Faulk


The transactions reported in this Form 4 were effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on September 12, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.785 to $4.94, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in footnote (2) to this Form 4.

/s/ Trempont Dominique by Charles Rogerson, as Attorney-in-Fact


Deferred share portion of quarterly Director retainer/fees.

/s/ Katherine M. Serevitch, Attorney-in-Fact


Common Stock

The transaction reported in this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on December 12, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.78 to $4.94 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in footnote (2) to this Form 4.

The options are fully vested and exercisable.

/s/ Sharan Sharat by Charles Rogerson, as Attorney-in-Fact


Common Stock

Includes 3,360 ESPP shares purchased in a non-reportable transaction on May 14, 2025.

Each RSU represents a contingent right to receive one share of the Issuer's common stock.

25% of the RSUs shall vest on the one-year anniversary of the Grant Date and one eighth of the RSUs shall vest every six months thereafter subject to the continued employment of Mr.Nader with the Company.


Share portion of quarterly Director retainer/fees.


Common Stock

Common Stock

Common Stock

The reporting person disclaims beneficial ownership of all securities held by spouse.

Ownership is represented by units held in a unitized stock fund through the issuer's 401(k) retirement plan as of July 31, 2025.

Each performance share unit represents a contingent right to receive one share of Corning Incorporated common stock.

Earned PSUs remain restricted until April 15, 2026, when they vest and convert to common stock, subject to service-based vesting requirement.

Earned PSUs remain restricted until April 15, 2027, when they vest and convert to common stock, subject to service-based vesting requirement.

The performance share units (PSUs) earned February 7, 2024 will vest 1/3 after 1 year from the February 8, 2023 grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.


Common Stock

These sales were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2025.

This stock option vests as to 20% of the shares on the first anniversary of the date of grant and vests as to 1/60th of the shares monthly thereafter.


Represents the withholding of shares to satisfy tax withholding obligation.

/s/ Sonwha Lee as attorney-in-fact for John J. Dolan


Common Stock

Common Stock

Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of Corning Incorporated common stock.

The restricted stock units (RSUs) vest 100% on April 15, 2027. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 14, 2028. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 15, 2026. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) granted on February 8, 2023 vest 1/3 after 1 year from the grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.


Common Stock

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.25 to $27.60. The reporting person undertakes to provide to Wolverine World Wide, Inc., any security holder of Wolverine World Wide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.97 to $6.20, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.


Common Stock

Common Stock

Common Stock


Represents a grant of Restricted Stock Units ("RSUs") under the Issuer's Employee Equity Incentive Plan. 100% of the RSUs will vest on August 11, 2026, contingent upon the Reporting Person's continued employment by the Company on that date.

Michael G. Andrews under POA for the benefit of Diego Reynoso


Shares held by the Price Family Trust, of which the reporting person and his wife are the trustees.

/s/ David Latchana, by Power of Attorney


Represents a grant of Restricted Stock Awards (RSUs) under the Issuer's Employee Equity Incentive Plan, which awards were granted in conjunction with the the cancellation of the Reporting Person's May 24, 2023 stock option awards. The grant is comprised of two sets of awards: a time-based RSU and a performance based RSU. The time-based RSU is for 9,197 shares and will vest in three tranches, with the final vesting on March 1, 2027 subject to the Reporting Person's continued employment with the Company on that date. The performance-based RSU is for 4,599 shares and is subject to the same performance criteria and vesting schedule as his previous May 24, 2023 stock option award, as disclosed in a Current Report on Form 8-K filed by the Issuer on May 22, 2023.

The shares reported include 29,997 shares of restricted stock subject to vesting conditions.

Michael G. Andrews under POA for the benefit of Philip A. Hodges


Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on August 8, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Includes 337,993 shares issuable upon the settlement of RSUs granted to the Reporting Person.


Common Stock

Common Stock

Common Stock

Common Stock


This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2025.

By: Gregory Scott Thomas attorney-in-fact For: Carl Jackson Alberty


Common Stock

Common Stock

Common Stock

Each performance share unit represents a contingent right to receive one share of Corning Incorporated common stock.

Earned PSUs remain restricted until April 15, 2026, when they vest and convert to common stock, subject to service-based vesting requirement.

Earned PSUs remain restricted until April 15, 2027, when they vest and convert to common stock, subject to service-based vesting requirement.

The performance share units (PSUs) earned February 7, 2024 will vest 1/3 after 1 year from the February 8, 2023 grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.


Includes 1,887,185 shares issuable upon the settlement of RSUs granted to the Reporting Person.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Raj Talluri


Common Stock

Each restricted stock unit represents a contingent right to receive one share of Organon common stock.

These restricted stock units vest and are distributed as shares of Organon & Co. common stock in three equal installments with 11,519 shares having vested on August 11, 2025 and the third and final vesting to occur on August 11, 2026.

/s/ Faye C. Brown, as Attorney-in-Fact for Dr. Juan Camilo Arjona Ferreira


Includes shares acquired under the New Mountain Finance Corporation dividend reinvestment plan since the filing of Mr. Ogens' previous beneficial ownership report on Form 4 on March 10, 2025.

Shares are owned indirectly by Mr. Ogens through trusts benefiting family members.


Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Offerpad Solutions Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date.

/s/ Adam Martinez, as Attorney-In-Fact for Donna Marie Corley


Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Offerpad Solutions Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) June 5, 2026 and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, RSUs will be settled in shares of the Issuer's Class A common stock within 45 days following the earliest to occur of: (i) the director's separation from service; (ii) a change in control of the Issuer; (iii) the director's death; or (iv) the director's disability.

/s/ Adam Martinez, as Attorney-in-fact for Ryan O'Hara


Open market purchase.

/s/Ephraim Starr, Attorney-in-fact for Lawrence Y. Lin


/s/ Adam Martinez, as Attorney-in-fact for Katherine Curnutte


Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on August 8, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Includes 173,141 shares issuable upon the settlement of RSUs granted to the Reporting Person.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Kristina Truong


This sale was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the Reporting Person on February 7, 2025.

The number of shares of KLA common stock includes 7,794.972 shares issuable upon vesting of restricted stock units ("RSUs").

/s/ Jeffrey S. Cannon, as attorney-in-fact for Mary Beth Wilkinson


The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025.

This sale price represents the weighted average sale price of the shares sold ranging from $3.61 to $3.645 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.


/s/ Adam Martinez, as Attorney-in-fact for Kenneth DeGiorgio


This sale was effected pursuant to the terms of a Rule 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025.

The number of shares of KLA common stock includes 1,951.639 shares issuable upon vesting of restricted stock units ("RSUs").

/s/ Jeffrey S. Cannon, as attorney-in-fact for Virendra A. Kirloskar


Includes 750 shares purchased pursuant to the 2021 Employee Stock Purchase Plan ("ESPP"), for the purchase period of February 1, 2025 to July 31, 2025. In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 31, 2025.


Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of IDA common stock.

Includes 56.410 shares in the reporting person's dividend reinvestment plan as of the transaction date.

These shares were received for no consideration upon the satisfaction of performance criteria underlying an award of performance-based units for the 2022-2024 performance period.

Comprised of 58.777 shares in the reporting person's dividend reinvestment plan as of the transaction date.

Total shares in 401(k) plan to date.

The restricted stock units vested on January 1, 2025.

The restricted stock units vest on January 1, 2028.

/s/ Cheryl W. Thompson, Attorney-in-Fact


Common Stock

Common Stock

Common Stock

Common Stock

Ownership is represented by units held in a unitized stock fund through the issuer's 401(k) retirement plan as of July 31, 2025.

Each restricted stock unit represents a contingent right to receive one share of Corning Incorporated common stock.

The restricted stock units (RSUs) vest 100% on April 15, 2027. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 14, 2028. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 15, 2026. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) granted on February 8, 2023 vest 1/3 after 1 year from the grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2025.

/s/ Rachel V. Friedenberg, Attorney-in-Fact for Obed D. Louissaint


Shares are held by the reporting person's children sharing the reporting person's household. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.

Christina A. Mecklenborg, Attorney-in-Fact


The reported sales were effected pursuant to a Rule 10b5-1 trading plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), adopted on November 20, 2024.

The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.06 to $51.0550 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.0701 to $52.00 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.97 to $51.86 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security
holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote


Common Stock

Common Stock

Common Stock

Common Stock

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $65.31 to $65.35, inclusive.  The reporting person undertakes to provide to Corning Incorporated, any security holder of Corning Incorporated, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth previously in this footnote.

Each performance share unit represents a contingent right to receive one share of Corning Incorporated common stock.

Earned PSUs remain restricted until April 15, 2026, when they vest and convert to common stock, subject to service-based vesting requirement.

Earned PSUs remain restricted until April 15, 2027, when they vest and convert to common stock, subject to service-based vesting requirement.

The performance share units (PSUs) earned February 7, 2024 will vest 1/3 after 1 year from the February 8, 2023 grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.

On December 2, 2020, the Compensation Committee approved the early vesting of one half of the stock options granted on May 15, 2020.  The remaining stock options vested ratably over three years from the grand date.


Class A Common Stock

Class A Common Stock

The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades ranging from $108.7550 to $109.1900.

This transaction was executed in multiple trades ranging from $110.00 to $110.9100.


Common Stock

The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2024. Mr. Renton holds various stock options that are expiring in 2025 and wished to put the plan in place to facilitate the orderly exercise of such options, including the options exercised and sold under this Form 4, which have an expiration date of August 13, 2025.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.375 to $19.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.46 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The stock option grant was issued on August 14, 2015, is fully vested and exercisable until its expiration date of August 13, 2025.

In addition to the remaining options to purchase 10,231 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 101,820 shares of common stock, which options vest according to their terms.


This sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 30, 2024 and the proceeds are intended to be used to satisfy tax withholding obligations in connection with the vesting of the underlying equity awards.


Represents number of securities owned by EN Holdings LLC, which is owned by the reporting person and his affiliates.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.90 to $65.89. The Reporting Person undertakes to provide Interactive Brokers Group, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (4) to this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.90 to $66.00.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.63 to $66.42.

This amount includes (a) Class A common stock attributable to vested restricted stock units that were awarded under the amended 2007 Stock Incentive Plan ("Plan") and (b) unvested restricted stock units that were awarded under the Plan.

/s/ Raymond Bussiere as authorized signatory for Earl H. Nemser


Reflects the withholding of shares of the Issuer's common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") on August 8, 2025. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Includes  824,667 shares issuable upon the settlement of RSUs granted to the Reporting Person.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Ajay Marathe


Common Stock

The restricted stock units will be settled solely in cash ("cash-settled RSUs").  Each cash-settled RSU is the economic equivalent of one share of Corning Incorporated common stock.

The restricted stock units (RSUs) granted on February 8, 2023 vest 1/3 after 1 year from the grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.


Includes 11,677 dividend equivalent restricted stock units received on previously granted RSU awards since the Reporting Person's last Form 4 filing.


Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan.  The award vests on March 21, 2026.

Restricted stock unit award to the reporting person pursuant to the Amrize Ltd 2025 Omnibus Incentive Plan.  The award vests on March 21, 2027.


Common Stock

Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of SPGI common stock.

As previously reported, the reporting person was granted 1,776 restricted stock units on 03/01/2023, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2023 and 33% on 12/31/2024 and the remaining 34% will vest on 12/31/2025. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.

As previously reported, the reporting person was granted 1,990 restricted stock units on 03/01/2024, subject to 3-year vesting. The restricted stock units vested 33% on 12/31/2024 and will vest 33% on 12/31/2025 and 34% on 12/31/2026. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.

As previously reported, the reporting person was granted 1,822 restricted stock units on 03/01/2025, subject to 3-year vesting. The restricted stock units will vest 33% on 12/31/2025, 33% on 12/31/2026 and 34% on 12/31/2027. Vested shares will be delivered to the reporting person no later than January 31 following the respective vesting date.


Common Stock

Common Stock

Common Stock

Common Stock

Each restricted stock unit represents a contingent right to receive one share of Corning Incorporated common stock.

The restricted stock units (RSUs) vest 100% on April 15, 2027. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 14, 2028. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.

The restricted stock units (RSUs) vest 100% on April 15, 2026. Events such as retirement, death, disability, and others specified in the agreement may result in vesting prior to the vesting date.


Class A Common Stock

The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades ranging from $110.00 to $110.08


This transaction was executed in multiple trades at prices ranging from $1.25 to $1.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.


This sale was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on August 30, 2024 and the proceeds are intended to be used to satisfy tax withholding obligations in connection with the vesting of the underlying equity awards.

/s/ Christian Gates, by power of attorney


Common Stock

Common Stock

Common Stock

Common Stock

Ownership is represented by units held in a unitized stock fund through the issuer's 401(k) retirement plan as of July 31, 2025.

The restricted stock units (RSUs) granted on February 8, 2023 vest 1/3 after 1 year from the grant date and 1/6 every 6 months thereafter until fully vested on the third anniversary of the grant date.


/s/ Emily Fuquay, by power of attorney for Michele J. Everard


Automatic grant issued on the date of the Company's 2025 Annual Meeting of Shareholders pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan and will vest at each quarter (September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026) provided that the recipient is still serving as a Director on the respective vesting dates.


/s/ Lawrence Lacerte (by Mauro Premutico as power of attorney)


Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award.

/s/ Christopher E. Ware, attorney-in-fact


Common Stock

Common Stock

Exercised as options were set to expire on November 16, 2025.

Exercised as options were set to expire on November 13, 2025.

The stock option exercised vested in 1/3rd increments beginning 11/16/2021 through
11/16/2023.

The stock option exercised vested in 1/5th increments beginning 11/13/2020 through
11/13/2024

Darrell Hammond by Power of Attorney for Cheryl Beranek


Common Stock

Sale prices ranged from $314.91 to $315.53.  Reporting Person will provide, upon request by the Commission staff, General Dynamics, or a General Dynamics shareholder, full information regarding the number of shares sold at each separate sales price.

Includes share activity under General Dynamics 401(k) plan since date of Reporting Person's last ownership report.

Fifty percent became exercisable on 03/06/2021, and the remaining fifty percent became exercisable on 03/06/2022.

Nicholas R. Barnaby, by power of attorney


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.0900 to $6.2950, inclusive. The reporting person undertakes to provide to SunOpta Inc., any security holder of SunOpta Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.


This transaction was executed in multiple trades at prices ranging from $5.34 to $5.37. The price reported above reflects the weighted average purchase price. The reporting person undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ Emily Fuquay, by power of attorney for Matthew R. Miller


Melissa Tinker - By POA from Christopher Caldwell


The shares are purchased in one transaction at a price provided in Column 4.


Restricted Stock Units granted pursuant to Issuer's 2011 Incentive Compensation Plan vesting 100% on July 11, 2026.

Includes an aggregate of 68,594 shares of common stock issuable pursuant to restricted stock units that have not vested.


The purchase was made in Swiss Francs at a price of CHF 37.37 per share, and converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8086).


The purchase was made in Swiss Francs at a price of CHF 37.83 per share, and converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8086).

The purchase was made in Swiss Francs at a price of CHF 38.60 per share, and converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8084).


/s/ Victor L. Cangelosi, pursuant to power of attorney


Timothy Bergwall by L. Dennis Hoffman, Jr. pursuant to a POA filed with the Commission.


The purchase was made in Swiss Francs at a price of CHF 37.40 per share, and converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8086).

The purchase was made in Swiss Francs at a price of CHF 38.87 per share, and converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8084).

The purchase was made in Swiss Francs at a price of CHF 38.86 per share, and converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8084).

The purchase was made in Swiss Francs at a price of CHF 37.94 per share, and converted into US Dollars using the transaction date exchange rate of (USD 1.00 = CHF 0.8100).


Common Stock

Restricted Stock Units

Common Stock

Each performance share represents a contingent right to receive one share of Stepan Company common stock.

The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2027.

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.

Vest ratably over three years beginning on the date shown.

/s/ Stephanie J. Pacitti, attorney-in-fact for Ruben D. Velasquez


Common Stock

The Reporting Person was issued 15,103,163 shares of Common Stock pursuant to a Series C Preferred Stock Exchange Agreement with the Issuer dated August 8, 2025, in exchange for 1,241,871 shares of 5.00% Cumulative Series C Convertible Preferred Stock and accrued and unpaid dividends thereon.

Under the Series C Preferred Stock Exchange Agreement with the Issuer, the parties agreed to an exchange price of $8.25 per share.

Owned directly by GO EK Ventures IV, LLC and indirectly by its sole member, B. Thomas Golisano.

Owned directly by B. Thomas Golisano.

The 5.00% Cumulative Series C Convertible Preferred Stock is convertible into Common Stock at any time on a ten-for-one basis and has no expiration date.


Represents 175,000 restricted stock of the issuer awarded to Mr. Hunter under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.


Represents 250,000 restricted stock of the issuer awarded to Mr. Pernice under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.


Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of the Reporting Person's previously reported Restricted Stock Unit ("RSU") Awards. Each RSU represents a contingent right to receive one share of common stock upon settlement.

Includes 34,038 unvested RSUs.

/s/ David M. Zlotchew, Attorney-in-Fact for Liana Pogosyan


Represents the transfer of 2,431 shares from directly held to a joint trust.

Includes 16,790 shares held in a joint trust.

David S. Maltz, attorney-in-fact for Theodore F. Craver, Jr.


Includes 180,083 unvested RSUs.

/s/ David M. Zlotchew, Attorney-in-Fact for Giordano Sordoni


Represents 625,000 restricted stock of the issuer awarded to Mr. Ross under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.


Includes 191,196 unvested RSUs.

/s/ David M. Zlotchew, Attorney-in-Fact for Dakota Semler


Amount increased due to dividend reinvestment.

Includes 33,721 shares held in a revocable joint trust.

Includes 33,321 shares held in a revocable joint trust.

Includes 32,921 shares held in a revocable joint trust.

/s/ David S. Maltz, attorney-in-fact for John T. Herron


Represents 62,500 restricted stock of the issuer awarded to Mr. Overholtzer under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.


/s/ Brittney Anderson, Attorney-in-Fact for Sterling A. Spainhour


Includes shares of restricted stock which vest at a rate of 20% per year commencing on April 24, 2026.

/s/ Steven Lanter, pursuant to power of attorney


Common Stock

Common Stock

Adoption date of referenced 10b5-1(c) plan is: 12-06-2024

Each Restricted Stock Unit represents a contingent right to receive one share of NWPX common stock.

The Restricted Stock Units vest in installments in January of 2026, 2027 and 2028.

Performance Shares vest in an amount ranging from 0-200% to the extent such Performance Shares are earned. Performance Shares are earned based on NWPX's total EBITDA margin over the measurement period.

Performance Shares vest in installments in March of 2026, 2027 and 2028.


Based upon shares sold at an average of $$1.2455. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.

Represents 175,000 restricted stock of the issuer awarded to Mr. Randall under the 2022 Equity Incentive Plan (the "2022 Plan"), which restricted stock vested upon issuance.


The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $ 109.34 to $109.50, inclusive. The reporting person undertakes to provide to AGCO Corporation, any security holder of AGCO Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.


/s/ Vito S. Pantilione, Jonathan D. Hill, Power of Attorney


The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024.


Common Stock, par value $0.001 per share

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person, dated August 21, 2024.

Reflects the weighted average sale price. The highest price at which shares were sold was $26.70 and the lowest price at which shares were sold was $25.79. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person has reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.

This amount includes 222,097 shares of restricted common stock subject to vesting and certain other restrictions.


By Martin D. Madaus 2011 Revocable Trust

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $111.72 to $112.35, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.


Represents the weighted average sale price.  Average price trade details available upon request.

Certain of these shares were granted under restricted stock awards and are subject to forfeiture.  Of such shares, 20,148 continue to be subject to forfeiture as of the date of this filing.

The reported transaction involves a transfer of securities by gift for which no payment of consideration was received by the reporting person.


/s/ Cristina Paradiso, attorney-in-fact for Richard A. Dierker


Common Stock

Each restricted stock unit represents a right to receive one share of MTRN common stock.

These restricted stock units vest in a single installment on the third anniversary of the grant date.

Expiration Date is the same as the Date Exercisable.

/s/Michelle R. Mekinda, as Attorney-In-Fact


Non-qualified stock options (right to buy)

Common Stock

Becomes exercisable in equal annual installments of 33% commencing 08/28/2020.


Common Stock, par value $0.01 per share

The options vested annually in five equal installments beginning on the first anniversary of the date of grant.


This amended Form 4 is being filed to correct the code used on the Reporting Person's original Form 4.

Includes shares of restricted stock granted pursuant to the Brookline Bancorp, Inc. 2021 Stock Option and Incentive Plan.

Janytra M. Brooks, by Marissa S. Martin, POA


On December 18, 2024, Horizon Kinetics Asset Management LLC (HKAM) filed an amendment to its Schedule 13D, in which it noted beneficial ownership of 3,578,173 shares and Murray Stahl's direct interest in 7,848 shares and his indirect interest in approximately 156,083 shares. The extent of HKAM's pecuniary interest in the shares beneficially owned is disclosed herein. Mr. Stahl does not exercise investment discretion with respect to the securities of the Issuer.


Common Stock

The option was previously reported in a filing dated 1/3/2019 as covering  8,653 securities at a strike price of $52 and the amounts are adjusted to reflect two  2-for-1 stock splits on 5/22/2019 and 5/21/2025 respectively.

Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 596 stock split adjusted securities since the reporting person filed a prior holdings report on 11/8/2024.

The option will fully vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable two years following the grant date and the remainder becoming exercisable proportionately each year thereafter.


Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.

Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan which vest in one year on March 11, 2026.


Common Stock

Common Stock

Common Stock

Common Stock

Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on May 1, 2024; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.

Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, 25% of which vest in three approximately equal annual installments commencing on March 6, 2025; and the remaining 75% of which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award.

Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive plan, which vest upon achievement of certain specified performance-based vesting criteria, which if achieved, such Awards would vest three years after the date of the Award on March 3, 2028.

Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.

Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on May 1, 2024.

Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 6, 2025.

Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three approximately equal annual installments commencing on March 3, 2026.


Common Stock

Common Stock

On May 22, 2019 and May 21, 2024, the Common Stock of Fastenal Company spilt 2-for-1 and the amounts reported have been adjusted to reflect these two stock splits.

The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.


Common Stock

Common Stock

Common Stock

Common Stock


Common Stock


Common Stock

Common Stock

Common Stock


Common Stock

Common Stock

Common Stock

Common Stock

Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan, which vest in three equal annual installments commencing on October 31, 2023.

Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan vest in three equal annual installments commencing on October 31, 2023.


Represents weighted average price.

Mr. Shaw has investment power over 500,000 shares as Trustee for the benefit of a family member. Mr. Shaw has voting control over the remainder of the shares pursuant to a voting agreement.

The Rule 10b5-1 Plan's date of adoption was August 22, 2024.


This transaction was executed in multiple trades at prices ranging from $150.00 to $150.60. The price reported reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer of a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.


The total holdings reflect an adjustment of 465 additional shares of Common Stock of CMS acquired as a result of dividend reinvestment or equivalents pursuant to the Restricted Stock awards granted in accordance with the provisions of the CMS Performance Incentive Stock Plan.


8% Unsecured Convertible Promissory Note

Series D-1 Convertible Preferred Stock

Common Stock

Each share of Series D-1 Preferred Stock is convertible into 10 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock").

The Series D-1 Convertible Preferred Stock will automatically convert into Common Stock on June 20, 2026, unless earlier converted into Common Stock in accordance with the terms of the Certificate of Designation for the Series D-1 Convertible Preferred Stock.

The Reporting Person could have voluntarily elected to convert the outstanding principal and interest of the 8% unsecured convertible promissory note (the "2024 Note") at any time while the 2024 Note was outstanding into shares of Series D-1 Convertible Preferred Stock at a price per share equal to $2.862. The outstanding principal and interest of the 2024 Note automatically converted into shares of Series D-1 Preferred Stock at a price per share equal to $2.862 on the date which is twelve months after the issue date of the 2024 Note. The 2024 Note was issued pursuant to the Issuer's 2024 Financing.

On August 08, 2025, the 2024 Note was converted into 18,880 shares of Series D-1 Preferred Stock.


Common Stock

Includes shares acquired pursuant to a dividend reinvestment feature of WEC Energy Group's ("WEC") Stock Plus Investment Plan in transactions exempt from Section 16 pursuant to Rule 16a-11.

This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.015 to $111.11, inclusive. The reporting person undertakes to provide to WEC, any security holder of WEC, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

This price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.62 to $111.0925, inclusive. The reporting person undertakes to provide to WEC, any security holder of WEC, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Includes shares acquired under WEC Energy Group, Inc.'s Employee Retirement Savings Plan (ERSP) in transactions exempt from Section 16(b) pursuant to Rule 16b-3(c) and exempt from reporting pursuant to Rule 16a-3(f)(1)(i)(B).  The number of shares in the ERSP attributable to any one participant varies with the price of the Common Stock.  The information in this report is based on a plan statement dated as of July 31, 2025.

Options vest 100% on the date indicated.


BLACKROCK CALIFORNIA MUNICIPAL INCOME TRUST


Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.


This figure does not include 101,750 shares held directly by Mr. Stahl.

For each indirect account, Mr. Stahl disclaims beneficial ownership except to the extent of his pecuniary interest, if any.


Reflects the settlement date, which is the date the price per share of the purchased shares and the number of shares being purchased was determined.

/s/Darren Thayer, Attorney-in-Fact for Gayle P. Starr


Melissa Tinker By POA from Carol Martin, Director


Represents the sale of shares, pursuant to a 10b5-1 Sales Plan, to pay the tax liability incident to the vesting of RSUs.

The price reported in Column 4 is single print.


The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated as of December 4, 2024.

By: Brooke R. Phillips For: Joseph L. Moskowitz


The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.7550 to $11.88, inclusive. The reporting person undertakes to provide Shenandoah Telecommunications Company, any security holder of Shenandoah Telecommunications Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

These shares are held in trust for the benefit of certain relatives of Mr. French. Mr. French disclaims beneficial ownership of the shares as to which he has no pecuniary interest and this filing is not an admission that Mr. French is the beneficial owner of such shares.


Spouse as custodian for child's OUTMA Account

Spouse as custodian for child's OUTMA accountg

Reporting person disclaims beneficial ownership

/s/ Cheryl M. Kirkbride by Margaret L. Conn, Attorney-in-Fact pursuant to Power of Attorney filed herewith


Common Stock, par value $0.0001

Common Stock, par value $0.0001

Reflects shares issued upon the exercise of publicly-traded warrants (the "Warrants") by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares and the Warrants. The Warrants were distributed by the Issuer on July 21, 2025 at no cost to the Reporting Person, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement dated July 21, 2025 between the Issuer and Computershare Trust Company N.A., as warrant agent (the "Warrant Agreement").

The shares and Warrants are held by the Rodgers Family Freedom and Free Markets Charitable Trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares and Warrants.

The shares and Warrants are held by the Rodgers Massey Revocable Living Trust dtd 4/4/11 for which the Reporting Person is a trustee and has voting and dispositive power over the shares and Warrants.

Includes 22,543 shares issuable upon the settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

The Warrants will expire and cease to be exercisable at 5:00 p.m. New York City time on October 1, 2026 (the "Expiration Date"). The Expiration Date is subject to automatic acceleration upon satisfaction of the early expiration price condition (as defined in the Warrant Agreement) and subject to the other terms of the Warrant Agreement.

The Warrants were distributed by the Issuer on July 21, 2025 at no cost to the Reporting Person, and each Warrant entitles the holder to purchase one share of common stock at an exercise price of $8.75 per share in accordance with the Warrant Agreement.

/s/ Arthi Chakravarthy, Attorney-in-Fact for Thurman J. Rodgers


No consideration was received in connection with this charitable gift.

The reporting person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.


These common units were purchased by Bayou City Energy Management LLC ("BCEM").

After the reported transactions, the reported common units are directly held 74,805,939 by BCE-Mach Aggregator LLC ("BCE Aggregator") and 10,085 by BCEM. BCE Aggregator is indirectly managed by BCEM. William W. McMullen is the Managing Partner of BCEM. Accordingly, each of the Reporting Persons may be deemed to beneficially own the securities directly held by BCE Aggregator and BCEM, as applicable, but disclaim beneficial ownership of such common units except to the extent of their respective pecuniary interest therein.

The Reporting Person is a Director of Mach Natural Resources GP LLC, the general partner of the Issuer (the "General Partner"). The Issuer is managed by the directors and executive officers of the General Partner.


These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.42, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.


This Form 4 is filed jointly by Olesen Value Fund L.P., Olesen Value Fund GP LLC, Olesen Capital Management LLC and Christian Olesen, the address of each of which is c/o Olesen Capital Management LLC, 185 Hudson Street, Suite 2539, Jersey City, NJ 07311 (collectively, the "Reporting Persons"). Each Reporting Person disclaims beneficial ownership of the shares of common Stock reported herein except to the extent of its or his pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such shares of Common Stock for purposes of Section 16 or for any other purpose.

Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Olesen Value Fund GP LLC, as the general partner of Olesen Value Fund L.P., may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.

Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Olesen Capital Management LLC, as the investment manager of Olesen Value Fund L.P., may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.

Shares of Common Stock beneficially owned directly by Olesen Value Fund L.P. Christian Olesen, as the managing member of Olesen Value Fund GP LLC and Olesen Capital Management LLC, may be deemed the beneficial owner of the shares of Common Stock beneficially owned by Olesen Value Fund L.P.


Mr. MacGregor is a Managing Manager of Hyperion Sprung Private Family Trust Management Company, LLC, trustee of The Noah Morgan Private Family Trust. Mr. MacGregor has no direct ownership of any of the Trust's shares.


The price in Column 4 is a weighted average of shares purchased at prices ranging from $4.225 to $4.25. The Reporting Person (RP) undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price.

Includes an additional 75,000 shares issuable pursuant to previously issued Restricted Stock Units: (i) 25,000 of such shares have vested and (ii) 50,000 of such shares will potentially vest in one-half increments on each of January 16, 2026, and January 16, 2027. All such unvested shares were previously reported on a Form 4 filing at the time of grant.

Includes an additional 50,000 shares issuable pursuant to previously issued Restricted Stock Units: (i) 33,333 of such shares have vested and (ii) 16,667 of such shares will potentially vest on August 4, 2026. All such unvested shares were previously reported on a Form 4 filing at the time of grant.

Includes an additional 40,000 shares issuable pursuant to previously issued Restricted Stock Units: 40,000 of such shares will potentially vest in one-third increments on each of January 18, 2026, January 18, 2027, and January 18, 2028. All such unvested shares were previously reported on a Form 4 filing at the time of grant.

/s/ John L. Cleary, II, attorney-in-fact


Includes (i) 5,908 unvested shares acquired pursuant to previously granted restricted stock unit awards and (ii) 69 shares acquired in June 2025 under the Garmin Ltd. Employee Stock Purchase Plan.

/s/ Paul E. Cassat, as attorney-in-fact for Edward J. Link


Shares gifted to a charitable organization.

/s/ Paul E. Cassat, as attorney-in-fact for Philip Straub


This Form 4 is filed late due to administrative oversight. The July 17, 2025 transaction reflects the transfer of the shares held by 2752128 Ontario Ltd. to the reporting person's personal name. No cash consideration was involved in the transaction.


Owned via Larchwood Management Partners Inc.

This Form 4 is filed late due to administrative oversight. The April 30, 2025 transaction represents a gift of 2,000,000 shares. The July 17, 2025 transaction reflects the transfer of the remaining shares held by Larchwood Management Partners Inc. to the reporting person's personal name. No cash consideration was involved in either transaction.


Reflects an open market purchase of 8,065 of the Issuer's Chess Depositary Interests ("CDIs") on August 11, 2025 (Australia)/August 10, 2025 (U.S.). CDIs are units of beneficial ownership in shares of common stock of the Company that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty. Limited, a subsidiary of ASX Limited, the company that operates the ASX. Each CDI represents one fully paid share of common stock. The transaction was executed in multiple block trades at prices ranging from $79.74 to $80.20. The price reported above reflects the weighted average purchase price. Details regarding aggregated purchase transactions will be provided upon request by the Commission staff, the issuer or a security holder of the issuer.

Price converted from Australian dollars into U.S. Dollars based on an exchange rate of $1 AUD to $0.6518 USD.

The reporting person disclaims beneficial ownership of the shares held by her child, which underly CDIs. This report should not be deemed an admission that the reporting person is the beneficial owner of her child's shares for purposes of Section 16 or for any other purpose.

/s/ James Sottile, attorney-in-fact for Antonia Korsanos


The sales were executed in multiple trades at prices ranging from $7.56 to $7.81. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $7.60 to $7.77. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $7.455 to $7.630. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The sales were executed in multiple trades at prices ranging from $7.50 to $7.66. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

/s/ James A. Heindlmeyer, as attorney-in-fact for Adam Rothstein


Non-Voting Ordinary Shares, No Par Value

The reported sales are between the Issuer and College Top Holdings, Inc., as part of the Issuer's share repurchase program and are intended to keep the Reporting Persons' ownership of Taboola's outstanding shares from reaching 25% or more. See Exhibit 99.1 for more information.

See Exhibit 99.1.


See Exhibit 99.1.


Common Stock

This amount represents 1,728,688 RSUs, 50% of which vested immediately upon grant, and the remaining 50% of which shall vest in equal installments on August 10, 2026 and August 10,2027, subject to the Reporting Person's ongoing compliance through each vesting date with the Separation and General Release Agreement between the Company and the Reporting Person dated August 10, 2025, which was previously disclosed on the Company's Current Report on Form 8-K filed with the SEC on August 11, 2025.

This total amount includes 864,344 RSUs, 50% of which will vest on August 10, 2026, and the remaining 50% will vest on August 10, 2027, subject to the Reporting Person's ongoing compliance through each vesting date with the Separation and General Release Agreement between the Company and the Reporting Person dated August 10, 2025, which was previously disclosed on the Company's Current Report on Form 8-K filed with the SEC on August 11, 2025.

The Reporting Person is the sole shareholder of ZRB Holdings Inc.


Class A Common Stock, par value $0.01 per share

The reporting person disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for Section 16 or any other purpose.

On August 8, 2025, Yorktown Energy Partners IX L.P. ("Yorktown IX"), Yorktown Energy Partners X L.P. ("Yorktown X"), and Yorktown Energy Partners XI L.P. ("Yorktown XI") sold shares of Class A Common Stock at a price of $18.75, before underwriting discounts and commissions, in connection with the exercise in full of the overallotment option granted by Yorktown IX, Yorktown X, and Yorktown XI, to the underwriters pursuant to the underwriting agreement for a registered underwritten secondary offering by the Issuer. The reported price is the price to the public in the secondary offering before underwriting discounts and commissions.

These securities are owned directly by Yorktown IX. The reporting person is a member and manager of Yorktown IX Associates LLC, the general partner of Yorktown IX Company LP, the General Partner of Yorktown IX.

These securities are owned directly by Yorktown X. The reporting person is a member and manager of Yorktown X Associates LLC, the general partner of Yorktown X Company LP, the General Partner of Yorktown X.

These securities are owned directly by Yorktown XI. The reporting person is a member and manager of Yorktown XI Associates LLC, the general partner of Yorktown XI Company LP, the General Partner of Yorktown XI.

A mathematical error was made on the Form 4 filed on March 27, 2025 that misstated the ending balance of the Class A Common Stock held by Yorktown IX. The reported number of 3,662,881 should have been reported as 3,625,044 to account for the properly reported sale on March 27, 2025 of 37,837 shares.


Represents an award of 500,000 restricted stock units (RSUs) that will vest in three equal installments on August 8, 2026, 2027 and 2028, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person.

Represents an award of 500,000 RSUs with performance based vesting conditions. These RSUs will vest upon the achievement of a relative total shareholder return of the Issuer's common stock during the period from August 8, 2025 to the earlier of (i) July 30, 2028, and (ii) the date of a change of control, measured relative to the Russell2000 index, subject to the terms set forth in an award agreement between the Issuer and the Reporting Person. The target number of these RSUs that may be earned is reported above; the maximum amount is 150% of the number reported.

Includes the awards described in footnotes (1) and (2) above.


Class A Common Stock

All of the shares underlying this option will vest on June 27, 2026, or one day prior to the Issuer's next Annual Meeting of Shareholders, whichever is earlier, subject to the Reporting Person's continued service through the applicable vesting date.


Class A Common Stock

The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.


Class A Common Stock


Class A Common Stock

The shares underlying this option vest in 48 equal monthly installments beginning on the one-month anniversary of the grant date, subject to the Reporting Person's continued service through the applicable vesting date.


Class B Common Stock

Class A Common Stock

Class B Common Stock

Class A Common Stock

Class B Common Stock

Class A Common Stock

Class A Common Stock

Represents a grant of restricted stock units, each of which represents a contingent right to receive a share of the Issuer's Class A common stock. The restricted stock units vested immediately upon grant.

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class B Common Stock.

The restricted stock units were granted on May 23, 2022.  1/16ths of the restricted stock units will vest on the first day of each three (3)-month period following May 1, 2022, with the first such quarterly vesting date to occur on August 1, 2022, subject to the Reporting Person's continuous service on the Board of Directors of the Issuer through each such date.

Each share of Class B Common Stock is convertible at any time at the option of the Reporting Person into one share of Class A Common Stock and has no expiration date. Each share of Class B Common Stock will convert automatically into one share of Class A Common Stock in connection with: (i) any transfer, whether or not for value, except for certain permitted transfers described in the Issuer's amended and restated certificate of incorporation, (ii) such time as the aggregate number of shares of Class B Common Stock outstanding ceases to represent 5% of the aggregate number of shares of Common Stock outstanding, (iii) the vote of 85% of the holders of Class B Common Stock outstanding; and (iv) following the date of the death or permanent disability of Better's founder.

Each restricted stock unit represents a contingent right to receive on share of the Issuer's Class A common stock.

The restricted stock units will vest on the business day immediately preceding the Issuer's next annual meeting of stockholders.


Class A Common Stock

The shares underlying this option vest as to 25% of the award on August 7, 2026, with the remainder vesting in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date.


Common Stock

The option will vest in full on the earlier of Heartflow, Inc.'s annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.

/s/ Angela Ahmad, Attorney-in-Fact for Julie A. Cullivan


Common Stock

Common Stock

Common Stock

Common Stock

Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

Each share of Series F preferred stock and Series F-1 preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.

/s/ Angela Ahmad, Attorney-in-Fact for William C. Weldon


Common Stock

/s/ Angela Ahmad, Attorney-in-Fact for Wayne J. Riley


Common Stock

Represents restricted stock units ("RSUs"), with a vesting commencement date of August 7, 2025 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.

The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.

/s/ Angela Ahmad, Attorney-in-Fact for John C.M. Farquhar


Common Stock

Common Stock

Upon the closing of Heartflow, Inc.'s ("Heartflow") initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of Heartflow's common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis.

/s/ Angela Ahmad, Attorney-in-Fact for Vikram Verghese


By Campbell Rogers 2019 Irrevocable Trust

Common Stock

/s/ Angela Ahmad, Attorney-in-Fact for Campbell D.K. Rogers, M.D.


Common Stock

Common Stock

Common Stock

1/4th of the options will vest on January 8, 2026, and the remaining shares will vest and become exercisable in monthly installments until January 8, 2029, subject to continued service through the applicable vesting date.

/s/ Angela Ahmad, Attorney-in-Fact for Marie L. Jones


Common Stock

Common Stock

Upon the closing of Heartflow, Inc.'s ("Heartflow") initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis.

/s/ Angela Ahmad, Attorney-in-Fact for Timothy C. Barabe


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis.

Presidio Management Group X, L.L.C. ("PMG X") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

/s/ Angela Ahmad, Attorney-in-Fact for Casey M. Tansey


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow, Inc.'s ("Heartflow") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

Mr. Lightcap is a controlling member of each of HCPCIV 1, LLC, HealthCor Partners Fund II, L.P. and HealthCor Partners Fund, L.P. and may be deemed to have voting and dispositive power with respect to the shares. Mr. Lightcap disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each share of Series E preferred stock automatically converted into approximately 0.6951 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis.

/s/ Angela Ahmad, Attorney-in-Fact for Jeffrey C. Lightcap


Common Stock

On August 11, 2025, the Reporting Person net exercised 1,730,000 private placement warrants.

Represents shares withheld in connection with the cashless exercise of warrants to pay the aggregate exercise price.

/s/ Sarah Slayen, Attorney-in-Fact for Michael Thompson


Common Stock

Represents a stock option that is immediately exercisable with respect to 74% of the underlying shares and 3.74% of the underlying shares become exercisable thereafter on each of December 15, 2021 and March 15 of each of the following years with the last installment becoming exercisable on January 1, 2027.

/s/ Sarah Slayen, Attorney-in-Fact for Bonny Simi


The restricted stock units (the "RSUs") granted to the Reporting Person on August 7, 2025 (the "Effective Date") are issued pursuant to the Verb Technology Company, Inc. 2019 Stock Incentive Plan, as amended. The RSUs will vest on the one-year anniversary of the Effective Date.


Represents the acquisition of shares upon the determination of the Compensation Committee of the Board of Directors of the Issuer that certain performance conditions were met with respect to certain performance stock units (PSUs) granted to the Reporting Person on August 24, 2022.

Represents shares that have been withheld by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting of PSUs.


The restricted stock units (the "RSUs") granted to the Reporting Person on August 7, 2025 (the "Effective Date") are issued pursuant to the Verb Technology Company, Inc. 2019 Stock Incentive Plan, as amended (the "Plan"). The RSUs will vest on the six-month anniversary following the successful and timely filing of the Company's first quarterly report, or Form 10-Q.


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions on August 11, 2025 at prices ranging from $37.2500 to $38.1650, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

/s/ Justin D. Mogford, Attorney-in-Fact for Lorin L. Brass


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions on August 8, 2025 at prices ranging from $37.65 to $37.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

/s/ Justin D. Mogford, Attorney-in-Fact for Wesley E. Kern


Common Stock

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 7, 2025 at prices ranging from $36.91 to $37.63, inclusive. The reporting person undertakes to provide to the issuer, any security of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 7, 2025 at prices ranging from $37.9950 to $38.2050, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 7, 2025 at prices ranging from $36.9100 to $37.7045, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 7, 2025 at prices ranging from $38.21 to $38.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

Represents a bona fide gift of the Issuer's common stock by the Reporting Person to charity.

The stock options vest in full on June 12, 2023, subject to continuous service of the reporting person as of such vesting date.

/s/ Justin D. Mogford, Attorney-in-Fact for Christopher S. Bradshaw


Common Stock

The option will vest as to 1/36th of the shares subject to the option on each monthly anniversary following August 7, 2025.

In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."


Common Stock


Co-Manager of EWL Grandchildren Fund LLC

UMH Properties, Inc.

UMH Properties, Inc.

UMH Properties, Inc.

UMH Properties, Inc.

Sale of shares.